Ventegra, Inc. Announces Formation of Nonprofit Public Benefit Corporation – Launch of Ventegra Foundation Aligned With Ventegra’s 100-Year Strategy

Ventegra Foundation expands steadfast commitment to create stronger and greater long-term value to all of its stakeholders

GLENDALE, Calif.--(BUSINESS WIRE)--Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical solutions to payors, providers, and patients, announces that the State of California has approved the issuance of the Articles of Incorporation of Ventegra Foundation. This signifies the historic launch of a Nonprofit Public Benefit Corporation.

Robert T. Taketomo, Pharm.D., MBA, President & CEO of Ventegra, Inc., and Chairman of the Board of the Ventegra Foundation, says, “With this move, Ventegra, Inc. has initiated our ‘100-year strategy’ to move into a more sustainable and reliable healthcare solution for the community we serve.”

Explaining the significance of this decision to obtain nonprofit status, Ventegra Board Member, Larry L. Georgopoulos, Pharm.D., Ph.C., College of Pharmacy at the University of New Mexico, says, “This launch represents an innovative break from the status quo in the administration of healthcare and pharmaceutical benefits. Ventegra Foundation will be strategically positioned to build on Ventegra, Inc.’s established track record and commitment of creating value and innovation for all stakeholders (payors, providers, and patients) in the communities we serve.”

Dr. Taketomo adds, “As a Nonprofit Public Benefit Corporation, Ventegra Foundation will have no obligation to shareholder earnings nor the risk of being flipped into a private equity or venture capital group. Instead, Ventegra Foundation will be owned by the community it serves and be governed by a Board of Directors, the majority of whom are selected by public charities.”

Ventegra Foundation Board Member Edward P. Kammerer, MD, Chief Quality Officer, Mosaic Life Care, Saint Joseph, Missouri, aptly sums up the value proposition of this new entity, explaining, “The U.S. healthcare industry is in need of disruption from the payors through the players. We at Ventegra Foundation intend to be that disruptor.”

“This is a proud moment in Ventegra’s history,” says Dr. Taketomo. He explains, “Transitioning our operations to a nonprofit corporation after 16 years of business represents a significant milestone for our company, our employees, our clients, and our partners. Furthermore, it is an important step toward improving the American healthcare system as a whole. By providing a more accessible, efficient solution in an industry plagued by perverse incentives, conflicts-of-interest and inertia, Ventegra Foundation will set a new standard for integrity in the administration of healthcare and pharmaceutical benefits.”

Further detailing the significance of this milestone achievement, Ventegra Foundation Board Member Guy L. Clifton, MD, CEO and Founder of Actin Care Groups, Crystal Lake, IL, states, “Ventegra has been a true partner to our member companies because of Ventegra’s alignment with our employers’ interests. Ventegra supports programs that a traditional Pharmacy Benefits Manager (PBM) will not because of the conflicts of interest that are endemic in healthcare administrative services. The new Ventegra Foundation is uniquely positioned to change that dynamic at scale.”

About Ventegra, Inc.

Ventegra, Inc. is the legacy Ventegra that is dedicated to servicing Ventegra Foundation. Over time, most of the assets of Ventegra, Inc. will transition over to Ventegra Foundation. www.ventegra.com

About Ventegra Foundation

Ventegra Foundation is the new nonprofit Public Benefit Corporation in formation that will be the basis for Ventegra going forward. A complex transition process will be initiated that will transfer the intellectual property and personnel of Ventegra, Inc. into Ventegra Foundation. It is expected that this transition will occur over a period of three to five years. www.ventegra.com

Peggy C. Frank, MBA
peggy@ventegra.com
818-642-6804